Core Viewpoint - Univest Securities has successfully closed a $15 million registered direct offering for Chijet Motor Company, focusing on electric vehicle performance and traditional fuel vehicles [1][3]. Group 1: Offering Details - Chijet Motor Company will sell 100,000,000 Class A ordinary shares at a price of $0.15 per share, with the option for pre-funded warrants [2]. - The gross proceeds from the offering amount to approximately $15 million [3]. - The offering was conducted under a shelf registration statement declared effective by the SEC on August 16, 2024 [4]. Group 2: Company Overview - Chijet Motor Company specializes in the development, manufacture, sales, and service of traditional fuel vehicles and new energy vehicles (NEVs) [7]. - The company operates a large modern vehicle production base in Jilin, China, and is constructing a factory in Yantai, China, dedicated to NEV production [7]. - Chijet's management team consists of industry veterans with extensive experience in various fields including engineering, design, and financial management [7]. Group 3: Univest Securities Overview - Univest Securities, established in 1994, provides a range of financial services including investment banking and advisory [6]. - The firm has raised over $1.5 billion in capital for issuers globally since 2019 and has completed around 100 transactions across various industries [6].

Core Points - MediWound has entered into a definitive securities purchase agreement for the sale of 1,734,105 ordinary shares at a price of $17.30 per share, aiming to raise approximately $30 million in gross proceeds [1] - The offering is expected to close around September 30, 2025, pending customary closing conditions [1] - The net proceeds will primarily support EscharEx's pre-commercial activities, enhance manufacturing capabilities, and cover general corporate purposes [1] - H.C. Wainwright & Co. is the exclusive placement agent for this offering [1]

Core Viewpoint - MediWound Ltd. has announced a registered direct offering of ordinary shares, aiming to raise approximately $30 million to support its pre-commercial activities for EscharEx and enhance manufacturing capabilities [1][2]. Group 1: Offering Details - The company will sell 1,734,105 ordinary shares at a price of $17.30 per share, with the offering expected to close around September 30, 2025, pending customary closing conditions [1]. - H.C. Wainwright & Co. is acting as the exclusive placement agent for this offering [2]. - The gross proceeds from the offering are anticipated to be about $30 million before deducting fees and expenses [2]. Group 2: Use of Proceeds - The net proceeds from the offering will primarily be used to support EscharEx's pre-commercial activities, enhance large-scale manufacturing capabilities, and for general corporate purposes [2]. Group 3: Company Overview - MediWound Ltd. is a biotechnology company focused on developing enzymatic therapies for non-surgical tissue repair, with its FDA-approved product NexoBrid for thermal burns [5]. - The company is advancing EscharEx, a late-stage investigational therapy for chronic wound debridement, which has shown clinical advantages over leading products in the market [5].

Core Viewpoint - Univest Securities, LLC has successfully closed a $2.9 million registered direct offering for WORK Medical Technology Group LTD, a medical device supplier in China [1][3]. Group 1: Offering Details - The offering involved the sale of 38,999,334 Class A ordinary shares at a purchase price of $0.075 per share [2]. - The gross proceeds from the offering were approximately $2.9 million [3]. - The offering was conducted under a shelf registration statement on Form F-3, which was declared effective by the SEC on September 15, 2025 [4]. Group 2: Company Overview - WORK Medical Technology Group LTD develops and manufactures Class I and II medical devices, with a diverse product portfolio of 21 products, including customized masks and medical consumables [7]. - The company has sold products in 34 provincial-level regions in China and has a presence in over 30 countries worldwide [7]. - WORK Medical Technology has received quality-related manufacturing designations and has registered 17 products with the U.S. FDA, allowing entry into the U.S. market [7]. Group 3: Univest Securities Overview - Univest Securities, LLC has been registered with FINRA since 1994 and provides a variety of financial services, including investment banking and advisory [6]. - The firm has raised over $1.3 billion in capital for issuers globally since 2019 and completed approximately 100 transactions across various industries [6].

Core Viewpoint - Multi Ways Holdings Limited has successfully closed the second tranche of a registered direct offering, raising a total of $1,485,000 through the sale of 9,000,000 ordinary shares and warrants [1][2]. Group 1: Offering Details - The offering was priced at $0.165 per ordinary share and accompanying warrant, with each warrant exercisable at $0.198 per share for five years [2]. - The net proceeds from this offering will be utilized for working capital and general corporate purposes [2]. Group 2: Company Background - Multi Ways Holdings Limited is a prominent supplier of heavy construction equipment for sales and rental in Singapore and the surrounding region, with over two decades of experience in the industry [6]. - The company serves a diverse customer base, including clients from Singapore, Australia, UAE, Maldives, Indonesia, and the Philippines, positioning itself as a reliable one-stop shop for heavy construction equipment [6]. Group 3: Legal and Advisory - Spartan Capital Securities, LLC acted as the exclusive placement agent for this offering, while Ortoli Rosenstadt LLP and Sichenzia Ross Ference LLP provided legal counsel to the company and the placement agent, respectively [3]. - The offering was conducted under an effective registration statement filed with the Securities and Exchange Commission [4].

Core Insights - Several companies have experienced significant stock price declines, impacting investor sentiment and market performance [1] Company Summaries Chijet Motor Company, Inc. (NASDAQ:CJET) - Stock price dropped to $0.19, reflecting a -33.69% change, with a yearly range of $0.078 to $2.99 [2] - The company focuses on innovation in the electric vehicle sector and has appointed Jason Miller as COO to lead its transition into digital currency [2] - Strategic integration of major cryptocurrencies like Bitcoin, Ethereum, and Solana into its balance sheet is planned [2] AtlasClear Holdings, Inc. (NYSE American:ATCH) - Experienced a -33.13% change, with stock price falling to $0.61, ranging from $0.137 to $26.94 over the year [3] - The company is navigating challenging market conditions under CEO Ilya Bogdanov, emphasizing its trading and settlement platform [3] - Recently closed a $3 million financing round with the potential to raise an additional $2 million [3] Envoy Medical, Inc. (NASDAQ:COCH) - Stock price fell to $0.90, marking a -30.55% change, with a price range of $0.88 to $3.99 [4] - The company offers innovative medical technologies for hearing loss and is led by CEO Brent T. Lucas [4] - Announced a $2.5 million registered direct offering and a concurrent private placement for additional shares [4] Market Outlook - Despite significant price declines, these companies continue to pursue innovation and growth, with leadership committed to navigating market challenges [5]

Group 1 - Cocrystal Pharma, Inc. closed a registered direct offering, raising approximately $4.7 million from the sale of 2,764,710 shares at a price of $1.70 per share [1][3] - The company also issued unregistered warrants for the purchase of up to 5,529,420 shares at an exercise price of $1.50 per share, potentially adding approximately $8.3 million in gross proceeds if fully exercised [1][3] - The net proceeds from the offering will be used for working capital and general corporate purposes [3] Group 2 - H.C. Wainwright & Co. served as the exclusive placement agent for the offering [2] - The common stock was offered under a "shelf" registration statement effective since May 26, 2023, with a final prospectus supplement filed with the SEC [4] - The unregistered warrants were offered in a private placement and have not been registered under the Securities Act [5] Group 3 - Cocrystal Pharma is a clinical-stage biotechnology company focused on developing innovative antiviral treatments for diseases such as influenza, viral gastroenteritis, COVID, and hepatitis [7]

Core Viewpoint - Multi Ways Holdings Limited has successfully closed a registered direct offering of 9,000,000 ordinary shares and warrants, raising gross proceeds of $1,485,000, which will be used for working capital and general corporate purposes [1][2]. Group 1: Offering Details - The offering was priced at $0.165 per ordinary share and accompanying warrant, with each warrant exercisable at $0.198 per share for five years following issuance [2]. - Spartan Capital Securities, LLC acted as the exclusive placement agent for this offering, while Ortoli Rosenstadt LLP and Sichenzia Ross Ference Carmel LLP served as legal counsel for the Company and the placement agent, respectively [3]. Group 2: Regulatory Information - The registered direct offering was conducted under an effective registration statement on Form F-1, initially filed with the Securities and Exchange Commission on March 28, 2025, and declared effective on September 10, 2025 [4]. Group 3: Company Overview - Multi Ways Holdings Limited is a prominent supplier of heavy construction equipment for sales and rental in Singapore and the surrounding region, with over two decades of experience in the industry [6]. - The Company is recognized as a reliable supplier of both new and used heavy construction equipment, serving customers from various countries including Singapore, Australia, UAE, Maldives, Indonesia, and the Philippines [6].

Core Viewpoint - Multi Ways Holdings Limited announced a registered direct offering of 9,000,000 ordinary shares and warrants, aiming to raise approximately $1,485,000 for working capital and general corporate purposes [1][2]. Group 1: Offering Details - The offering is priced at $0.165 per ordinary share and accompanying warrant, with each warrant exercisable at $0.198 per share for five years [2]. - The offering is expected to close on or about September 15, 2025, subject to customary closing conditions [3]. Group 2: Company Background - Multi Ways Holdings is a leading supplier of heavy construction equipment for sales and rental in Singapore and the surrounding region, with over two decades of experience [5]. - The company serves a diverse customer base, including clients from Singapore, Australia, UAE, Maldives, Indonesia, and the Philippines, positioning itself as a one-stop shop for heavy construction equipment [5].

Core Viewpoint - Inno Holdings Inc. has successfully closed a registered direct offering, raising approximately $7.2 million through the sale of common stock and pre-funded warrants, with the transaction aimed at supporting general corporate purposes and working capital [1][3]. Group 1: Offering Details - The offering included the sale of 1,200,000 shares of common stock at a price of $3.60 per share and pre-funded warrants to purchase 800,000 shares, with the pre-funded warrants priced at $3.59999 each [2]. - Upon closing, 285,000 pre-funded warrants were exercised, resulting in the issuance of 285,000 shares of common stock [2]. Group 2: Financial Proceeds and Use - The company received aggregate gross proceeds of approximately $7.2 million from the offering, which closed on September 11, 2025 [3]. - The net proceeds from the offering are expected to be utilized for general corporate purposes, including working capital [3]. Group 3: Company Overview - Inno Holdings Inc. is focused on building technology and electronic products trading, aiming to revolutionize the construction industry with proprietary cold-formed steel framing, AI-driven design, and automation [6]. - The company is expanding its sales and distribution network in electronic product trading, seeking to enhance commercial value for business partners and increase enterprise value for shareholders [6].